Li Chen, co-founder and CEO of Hua Medicine, who previously ran Swiss group Roche’s Chinese research and development arm. Photo: Reuters

China's Hua Medicine appoints former Merrill banker as new CFO ahead of listing

George Lin will be responsible for corporate finance as well as helping commercialise and license drugs at the diabetes-focused biopharmaceutical firm

Topic |   IPO

TOP PICKS

Li Chen, co-founder and CEO of Hua Medicine, who previously ran Swiss group Roche’s Chinese research and development arm. Photo: Reuters
READ FULL ARTICLE